BRIEF published on 10/21/2024 at 20:05, 1 year 8 months ago ABIONYX Pharma receives positive EMA opinion for CER-001 ABIONYX Pharma CER-001 EMA AMM LCAT Deficiency
PRESS RELEASE published on 10/21/2024 at 20:00, 1 year 8 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma reçoit un avis positif de l'EMA pour le CER-001 dans la Déficience en LCAT. L'EMA admissible à la soumission de deux lots prospectifs de validation du procédé de fabrication ABIONYX Pharma CER-001 EMA LCAT Validation Du Procédé
PRESS RELEASE published on 10/21/2024 at 20:00, 1 year 8 months ago Inside Information / Other news releases ABIONYX Pharma receives positive feedback from EMA for CER-001 in LCAT Deficiency, allowing submission of data from 2 prospective process validation batches for MAA manufacturing ABIONYX Pharma CER-001 EMA LCAT Deficiency Process Validation Batches
BRIEF published on 08/22/2024 at 18:05, 1 year 10 months ago ABIONYX Pharma : Bilan du 1er semestre 2024 Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
BRIEF published on 08/22/2024 at 18:05, 1 year 10 months ago ABIONYX Pharma: Review of the first half of 2024 Biotechnology Fundraising Treasury Turnover ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 10 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma publie sa position de trésorerie du 1er semestre 2024 avec un chiffre d’affaires consolidé de 2,4 M€. Levée de fonds de 3,4 M€ pour renforcer la trésorerie Chiffre D'affaires Biotechnologie Trésorerie Levée De Fonds ABIONYX Pharma
PRESS RELEASE published on 08/22/2024 at 18:00, 1 year 10 months ago Inside Information / Other news releases ABIONYX Pharma reports €2.4m sales and €5.3m cash position for H1 2024, focused on innovative therapies. Raised €3.4m for sepsis program in the US Sales Cash Position Innovative Therapies ABIONYX Pharma Sepsis
BRIEF published on 07/01/2024 at 09:27, 2 years ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
BRIEF published on 07/01/2024 at 09:27, 2 years ago ABIONYX finalise avec succès une augmentation de capital de 3,4 millions d'euros Augmentation De Capital Actions Et Bons De Souscription Biotechnologies ABIONYX Développement De La Septicémie
PRESS RELEASE published on 07/01/2024 at 09:22, 2 years ago Inside Information / Other news releases ABIONYX successfully completes a capital increase of c.€3.4 million through the issuance of shares with warrants. The fundraising aims to strengthen the company's cash position for its development in sepsis and the United States Fundraising Capital Increase Sepsis ABIONYX Shares With Warrants
Published on 07/11/2026 at 02:50, 12 hours 41 minutes ago Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 13 hours 31 minutes ago Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 13 hours 31 minutes ago Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 15 hours 31 minutes ago Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
Published on 07/11/2026 at 00:00, 15 hours 31 minutes ago LNG Energy Group Provides Operational Update
Published on 07/11/2026 at 04:00, 11 hours 31 minutes ago CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027
Published on 07/11/2026 at 04:00, 11 hours 31 minutes ago L’Université chinoise de Hong Kong (CUHK) se classe parmi les 20 meilleures universités mondiales dans le classement mondial des universités 2027 de Quacquarelli Symonds (QS)
Published on 07/10/2026 at 18:40, 20 hours 51 minutes ago AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives
Published on 07/10/2026 at 17:45, 21 hours 46 minutes ago WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026
Published on 07/10/2026 at 18:00, 21 hours 31 minutes ago Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 18:00, 21 hours 31 minutes ago Bilan semestriel du contrat de liquidité de la société CEGEDIM
Published on 07/10/2026 at 17:45, 21 hours 46 minutes ago Bilan semestriel de mise en œuvre du contrat de liquidité
